ArticleJournal of cancer research and clinical oncology2014

BRCA1 promoter methylation is a marker of better response to platinum-taxane-based therapy in sporadic epithelial ovarian cancer.

T Ignatov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.